For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...
FAECAL microbiota transplantation (FMT) shows promise in treating ulcerative colitis (UC), with specific gut microbial ...
Recommendation based on the findings from the Phase 3 QUASAR programme in ulcerative colitis 1. Beerse, Belgium (28 February 2025) - Johnson & Johnson today announced that the Com ...
A new study published in BMC Gastroenterology identified that patients with inflammatory bowel disease (IBD), such as Crohn's ...
20h
Announced rosnilimab, a PD-1 depleter and agonist, achieved positive results from Phase 2b rheumatoid arthritis (RA) trial and highest-ever reported CDAI LDA response over 6 monthsFull clinical and ...
The treatment has gained approval in the European Union (EU) for a range of conditions, including psoriatic arthritis, ...
Announced rosnilimab, a PD-1 depleter and agonist, achieved positive results from Phase 2b rheumatoid arthritis (RA) trial and highest-ever reported CDAI LDA response over 6 monthsFull clinical and tr ...
That basic concept is why tons of people on social media are posting about a viral new product: Coconut Cult’s chocolate ...
During respiratory illness season there a more graphic, yet shorter-lasting virus making the rounds especially among kids: ...
Q2 2025 Earnings Conference Call February 26, 2025 5:00 PM ETCompany ParticipantsSilviu Itescu - Chief Executive ...
21hon MSN
Specialists from the Digestive System Department at Hospital Germans Trias have conducted and published a unique study that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback